✦ LIBER ✦

Phase II Trial of Neoadjuvant Chemotherapy Using Alternating Doublets in Non-Small-Cell Lung Cancer

✍ Scribed by Renato G. Martins; Rodrigo Dienstmann; Paulo de Biasi; Karina Dantas; Valdelice Santos; Edson Toscano; Walter Roriz; Mauro Zamboni; Aureliano Sousa; Isabele A. Small; Denise Moreira; Carlos G. Ferreira; Mauro Zukin

Book ID: 115076651
Publisher: CIG Media Group, LP.
Year: 2007
Tongue: English
Weight: 354 KB
Volume: 8
Category: Article
ISSN: 1525-7304
DOI: 10.3816/clc.2007.n.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of alternating 4 chemothe

Phase II trial of alternating 4 chemotherapy regimens in non-small cell lung cancer

✍ Stewart, D.J; Shamji, F; Maziak, D; MacLeod, P; Tomiak, E 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 107 KB

P-538 Alternating doublets as neoadjuvan

P-538 Alternating doublets as neoadjuvant chemotherapy in patients (pts) with operable non-small cell lung cancer (NSCLC)

✍ Zukin, Mauro; Ferreira, Carlos Gil; Torquato, Emanuel; Madeira, Denise; Roriz, W 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 176 KB

Phase II study of alternating chemothera

Phase II study of alternating chemotherapy regimens for advanced non-small cell lung cancer

✍ Stewart, David J; Tomiak, Eva; Shamji, Farid M; Maziak, Donna E; MacLeod, Peter 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 119 KB

Standard versus alternating non-cross-re

Standard versus alternating non-cross-resistant chemotherapy in extensive small cell lung cancer: An EORTC phase iii trial

✍ P.E. Postmus; G. Scagliotti; H.J.M. Groen; F. Gozzelino; J.Th.W. Burghouts; D. C 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 658 KB

A phase I study of dose-dense “alternati

A phase I study of dose-dense “alternating doublets” chemotherapy with filgrastim (rhG-CSF) support in advanced non-small cell lung cancer (NSCLC)

✍ Watson, S.M; Gordon, G.S; Mauer, A.M; Rudin, C.R; Hoffman, P.C; Krauss, S.A; Sze 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 111 KB

A phase II trial testing gemcitabine as

A phase II trial testing gemcitabine as second-line chemotherapy for non small cell lung cancer

✍ Sculier, J.P; Lafitte, J.J; Berghmans, T; Thiriaux, J; Lecomte, J; Efremidis, A; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 77 KB